Genomic Valley Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	-	0.45	0.06	0.41	0.03	0.11	Upgrade
Cash & Short-Term Investments	0.07	0.45	0.06	0.41	0.03	0.11	Upgrade
Cash Growth	-98.31%	644.62%	-85.30%	1441.91%	-76.61%	-69.66%	Upgrade
Accounts Receivable	-	22.14	25.3	22.17	-	0.65	Upgrade
Other Receivables	-	-	0.02	0.02	0.15	0.09	Upgrade
Receivables	-	22.14	25.32	22.2	0.15	0.74	Upgrade
Inventory	-	2.84	-	-	-	-	Upgrade
Other Current Assets	-	0.78	3.72	3.16	11.19	0.79	Upgrade
Total Current Assets	-	26.22	29.1	25.77	11.37	1.64	Upgrade
Property, Plant & Equipment	-	0.09	0.02	0.03	17.47	63.34	Upgrade
Long-Term Investments	-	-	0.17	4.35	4	-	Upgrade
Other Intangible Assets	-	-	-	-	0.08	0.13	Upgrade
Long-Term Deferred Tax Assets	-	-	-	-	0	0.08	Upgrade
Other Long-Term Assets	-	9.05	14.05	14.05	5.05	11	Upgrade
Total Assets	-	43.57	43.34	44.2	37.97	76.18	Upgrade
Accounts Payable	-	0.1	6.02	6.11	-	0.4	Upgrade
Accrued Expenses	-	0.31	0.03	1.74	0.25	0.18	Upgrade
Current Income Taxes Payable	-	0.85	-	-	-	-	Upgrade
Other Current Liabilities	-	3.33	1.87	1.09	1.9	8.13	Upgrade
Total Current Liabilities	-	4.58	7.91	8.93	2.14	8.71	Upgrade
Long-Term Debt	-	-	-	-	-	15.47	Upgrade
Long-Term Deferred Tax Liabilities	-	0.01	0	0	-	-	Upgrade
Other Long-Term Liabilities	-	-	-	-	7.05	7.12	Upgrade
Total Liabilities	-	4.58	7.92	8.94	9.19	31.3	Upgrade
Common Stock	-	30.55	30.55	30.55	30.55	30.55	Upgrade
Retained Earnings	-	5.97	2.41	2.26	-4.22	-4.13	Upgrade
Comprehensive Income & Other	-	2.47	2.47	2.47	2.47	18.47	Upgrade
Shareholders' Equity	39.26	38.98	35.42	35.27	28.79	44.88	Upgrade
Total Liabilities & Equity	-	43.57	43.34	44.2	37.97	76.18	Upgrade
Total Debt	-	-	-	-	-	15.47	Upgrade
Net Cash (Debt)	0.07	0.45	0.06	0.41	0.03	-15.36	Upgrade
Net Cash Growth	-98.31%	644.62%	-85.30%	1441.91%	-	-	Upgrade
Net Cash Per Share	0.02	0.15	0.02	0.14	0.01	-5.03	Upgrade
Filing Date Shares Outstanding	3.51	3.05	3.05	3.05	3.05	3.05	Upgrade
Total Common Shares Outstanding	3.51	3.05	3.05	3.05	3.05	3.05	Upgrade
Working Capital	-	21.64	21.19	16.84	9.23	-7.08	Upgrade
Book Value Per Share	12.64	12.76	11.60	11.55	9.42	14.69	Upgrade
Tangible Book Value	39.26	38.98	35.42	35.27	28.71	44.75	Upgrade
Tangible Book Value Per Share	12.64	12.76	11.60	11.55	9.40	14.65	Upgrade
Land	-	-	-	-	20.55	54.66	Upgrade
Machinery	-	0.13	0.03	2.97	3.27	9.07	Upgrade
Construction In Progress	-	-	-	-	-	4.88	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.